[18f]gtp1
Small moleculeexperimentalImaging agent
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 4, 2017 (NCT03289143)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05464368 | Phase 1 | Aug 31, 2022 | Roche, Washington University in St. Louis |
| NCT04566003 | Phase 1 | Oct 26, 2020 | Genentech |
| NCT03977584 | Phase 2 | Jun 10, 2019 | Genentech, Roche, University of Arizona |
| NCT03828747 | Phase 2 | Jan 30, 2019 | Genentech, Roche |
| NCT03289143 | Phase 2 | Oct 4, 2017 | Genentech |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genentech | For profit | 4 | 4 | 2 | 2017 |
| Roche | For profit | 3 | 0 | 2 | 2019 |
| University of Arizona | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1